Rising incidence of systemic autoimmune inflammatory rheumatic diseases during the COVID-19 pandemic: a geographical cohort study
Objective The natural infection with SARS-CoV-2, or vaccination against it, has been postulated to directly contribute to an increase in the incidence of autoimmune inflammatory rheumatic diseases (AIIRDs). Conversely, preventive measures limiting access to healthcare services could have resulted in...
Saved in:
| Main Authors: | Marina Davoli, Silvia Laura Bosello, Enrico De Lorenzis, Salvatore Soldati, Mirko Di Martino, Maria Antonietta D’Agostino, Gerlando Natalello, Paolo Parente, Andrea Barbara |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-06-01
|
| Series: | RMD Open |
| Online Access: | https://rmdopen.bmj.com/content/11/2/e005227.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hydroxychloroquine in rheumatic autoimmune disorders and beyond
by: Eliise Laura Nirk, et al.
Published: (2020-07-01) -
Bronchiolar disorders in systemic autoimmune rheumatic diseases
by: Yanisa Kluanwan, et al.
Published: (2025-04-01) -
Diagnosis of rheumatic and autoimmune diseases datasetDataverse
by: Mohammed Fadhil Mahdi, et al.
Published: (2025-06-01) -
Molecular mimicry in the pathogenesis of autoimmune rheumatic diseases
by: Michaela Fehringer, et al.
Published: (2025-06-01) -
Safety of Cyclophosphamide Therapy in Autoimmune Rheumatic Diseases
by: Ramaswamy Subramanian, et al.
Published: (2019-01-01)